根据《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指 引第2号——创业板上市公司规范运作》等有关法律、法规、规范性文件以及《公 司章程》《独立董事工作制度》等有关规定，作为山东阳谷华泰化工股份有限公 司（以下简称"公司"）的独立董事，本着谨慎的原则，基于独立判断的立场，就 公司第五届董事会第二十二次会议相关事项发表如下独立意见： 一、《关于续聘会计师事务所的议案》的独立意见 山东阳谷华泰化工股份有限公司独立董事 关于第五届董事会第二十二次会议相关事项的独立意见 独立董事：张辉玉 朱德胜 张洪民 二〇二三年十一月十六日 大信会计师事务所（特殊普通合伙）具有证券业从业资格，具有上市公司审 计工作的丰富经验和职业素养，能够满足公司审计工作的要求。其在担任公司审 计机构期间，能够按照《企业会计准则》和《审计准则》的有关规定对公司进行 审计，勤勉尽责、公允合理地发表独立审计意见。本次续聘审计机构的审议程序 符合相关法律、法规和《公司章程》的规定，不存在损害公司和全体股东利益的 情形。我们一致同意续聘大信会计师事务所（特殊普通合伙）为公司2023年度审 计机构并同意将该议案提交股东大会审议。 ...

| 证券代码：300121 | 证券简称：阳谷华泰 公告编号：2023-103 | | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | 山东阳谷华泰化工股份有限公司 第五届监事会第十八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 山东阳谷华泰化工股份有限公司（以下简称"公司"）第五届监事会第十八 次会议于 2023 年 11 月 15 日在公司三楼会议室召开。会议通知于 2023 年 11 月 9 日专人及通讯方式送达全体监事。应参加会议监事 3 人，实际参加会议监事 3 人。会议由监事会主席柳章银先生主持，董事会秘书列席了会议，符合《中华人 民共和国公司法》和《公司章程》的规定。 二、监事会会议审议情况 会议以记名投票表决方式，审议并通过了以下议案： 1、审议通过《关于续聘会计师事务所的议案》 监事会认为，大信会计师事务所（特殊普通合伙）作为公司 2022 年度的审 计机构，在审计过程中遵守职业道德规范，勤勉、尽职地发表独立审计意见，客 观、公正地出具各项专业报告。续聘大信会计师事务所 ...

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2023-101 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 山东阳谷华泰化工股份有限公司 关于收到公司控股股东、实际控制人提议 回购公司股份的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东阳谷华泰化工股份有限公司（以下简称"公司"）于 2023 年 11 月 9 日收 到公司控股股东、实际控制人王传华先生《关于提议山东阳谷华泰化工股份有限公 司回购公司股份的函》。王传华先生提议公司以自有资金通过深圳证券交易所交易 系统以集中竞价交易方式回购公司已发行的部分人民币普通股（A 股）股票，具体 情况如下： 一、提议人的基本情况 1、提议人：公司控股股东、实际控制人王传华先生。截至本公告披露日，王传 华先生持有公司股份 93,557,010 股，占公司总股本的 22.88%。 2、是否享有提案权：是。 3、提议时间：2023 年 11 月 9 日。 二、提议回购股份的原因和目的 基于对公司未来发展前景的信心和对公司价值的高度 ...

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2023-100 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 山东阳谷华泰化工股份有限公司关于 子公司签订募集资金四方监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意山东阳谷 华泰化工股份有限公司向不特定对象发行可转换公司债券注册的批复》（证监许可 〔2023〕1091 号）同意注册，山东阳谷华泰化工股份有限公司（以下简称"公司"） 向不特定对象发行 6,500,000 张可转换公司债券，每张面值为 100 元，募集资金总额 人民币 650,000,000.00 元，扣除发行费用人民币 5,847,650.42 元（不含税），实际募 集资金净额为人民币 644,152,349.58 元。信永中和会计师事务所（特殊普通合伙）已 对 公 司 上 述 募 集 资 金 到 位 情 况 进 行 了 审 验 ， 并 出 具 了 《 验 资 报 告 》 ...

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2023-099 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 山东阳谷华泰化工股份有限公司 关于使用部分闲置募集资金及自有资金 进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 山东阳谷华泰化工股份有限公司（以下简称"公司"）于 2023 年 8 月 21 日召 开公司第五届董事会第十八次会议及第五届监事会第十四次会议，审议通过了《关 于使用部分闲置募集资金及自有资金进行现金管理的议案》，同意公司及下属子公 司使用不超过人民币 65,000 万元（含本数）的暂时闲置募集资金及不超过 20,000 万元（含本数）的自有资金进行现金管理，其中，暂时闲置募集资金包括继续使用 2022 年度向特定对象发行股票的募集资金不超过人民币 10,000 万元（包含本数）， 及使用向不特定对象发行可转换公司债券的募集资金不超过人民币 55,000 万元（包 含本数）。上述资金用于购买由金融机构发行的投资期限不超过 12 个月、安全性 ...

山东阳谷华泰化工股份有限公司 关于阳谷转债转股价格调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 | 证券代码：300121 | 证券简称：阳谷华泰 公告编号：2023-098 | | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | 特别提示： 1、债券简称：阳谷转债，债券代码：123211 一、关于可转换公司债券转股价格调整的相关规定 根据中国证券监督管理委员会（以下简称"中国证监会"）《关于同意山东 阳谷华泰化工股份有限公司向不特定对象发行可转换公司债券注册的批复》（证 监许可〔2023〕1091 号），山东阳谷华泰化工股份有限公司（以下简称"公司"） 向不特定对象发行 6,500,000 张可转换公司债券，每张面值为 100 元，募集资金总 额人民币 65,000 万元。本次发行可转换公司债券的上市时间为 2023 年 8 月 14 日， 债券简称为"阳谷转债"，债券代码为"123211"。 根据中国证监会关于可转换公司债券发行的相关规定及《山东阳谷华泰化工 股份有限公司向不特定对象发行可转换公司债券募集说明书 ...

| 证券代码：300121 | 证券简称：阳谷华泰 公告编号：2023-097 | | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | 山东阳谷华泰化工股份有限公司关于 2021 年限制性股票激励计划第二个归属期归属结果 暨股份上市的公告 公司分别于 2021 年 9 月 17 日、2021 年 10 月 12 日召开第四届董事会第二十 六次会议、2021 年第一次临时股东大会审议通过了《关于<山东阳谷华泰化工股份 有限公司 2021 年限制性股票激励计划（草案）>及其摘要的议案》《关于<山东阳 谷华泰化工股份有限公司 2021 年限制性股票激励计划实施考核管理办法>的议案》 等议案。本次激励计划的主要内容如下： 1 本次归属的限制性股票上市流通日：2023 年 11 月 6 日 本次符合归属条件的激励对象共 142 人 限制性股票拟归属数量：421.80 万股，占归属前公司总股本的 1.04% 归属股票来源：公司向激励对象定向发行的本公司 A 股普通股股票 1、股权激励方式：限制性股票（第二类限制性股票）。 2、标的股票来源：公司向激励对象定向发行公司 A 股普通股股票。 3 ...

Financial Performance - The company's revenue for Q3 2023 was ¥962,960,799.14, representing a 10.05% increase year-over-year, while the year-to-date revenue decreased by 2.60% to ¥2,627,052,254.08[6] - Net profit attributable to shareholders for Q3 2023 was ¥49,933,444.59, a significant decrease of 66.51% compared to the same period last year, and a year-to-date decrease of 40.87% to ¥259,312,290.02[6] - Basic earnings per share for Q3 2023 dropped to ¥0.12, down 70.00% year-over-year, with diluted earnings per share reflecting the same figure[6] - Total operating revenue for Q3 2023 was CNY 2,627,052,254.08, a decrease of 2.59% compared to CNY 2,697,113,013.95 in the same period last year[23] - Net profit for Q3 2023 was CNY 259,312,290.02, down 40.9% from CNY 438,568,058.44 in the previous year[24] - Earnings per share decreased to CNY 0.64, compared to CNY 1.17 in the same quarter last year[24] - The total comprehensive income for Q3 2023 was CNY 258,988,097.54, down from CNY 438,857,249.46 in the previous year[24] Assets and Liabilities - Total assets as of September 30, 2023, increased by 23.73% to ¥4,381,674,708.82 compared to the end of the previous year[6] - Total liabilities increased to CNY 1,246,935,049.26, compared to CNY 761,959,868.02 in the previous year, reflecting a significant rise in financial obligations[21] - The total equity attributable to shareholders increased by 12.79% to ¥3,134,739,659.56 compared to the end of the previous year[6] - The company's total equity rose to CNY 3,134,739,659.56, up from CNY 2,779,292,001.71 year-on-year[21] Cash Flow - The net cash flow from financing activities for the first nine months of 2023 was ¥513,227,028.16, a substantial increase of 553.28% due to funds received from convertible bonds[14] - The net cash flow from operating activities for the period was ¥260,765,225.41, a decrease of 24.9% compared to ¥347,256,281.67 in the previous period[25] - Cash inflow from financing activities totaled ¥803,204,716.98, up from ¥548,729,996.68 in the previous period, marking a 46.2% increase[27] - The net cash flow from financing activities was ¥513,227,028.16, compared to ¥78,561,541.67 in the previous period, indicating a substantial improvement[27] - The company reported a decrease in cash received from tax refunds to ¥46,953,455.35 from ¥61,307,456.22 in the previous period[25] Research and Development - Research and development expenses for the first nine months of 2023 rose by 34.49% to ¥76,288,397.56, attributed to increased material and labor costs[12] - Research and development expenses increased to CNY 76,288,397.56, up 34.5% from CNY 56,725,020.36 in the previous year, indicating a focus on innovation[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,338[16] - The top shareholder, Wang Chuanhua, holds 23.11% of the shares, amounting to 93,557,010 shares[16] - The company has not disclosed any related party relationships among the top shareholders, except for Wang Chuanhua, Yin Yueren, and Wang Wenbo, who are identified as acting in concert[17] Investment Activities - The company recorded a net cash outflow from investing activities of -¥567,641,699.79 for the first nine months of 2023, a 343.46% increase in outflow compared to the same period last year[14] - Total cash inflow from investment activities was ¥429,162,385.40, significantly higher than ¥4,213,068.50 in the previous period[25] - The company received ¥645,754,716.98 from investment absorption, a significant increase from ¥282,259,996.68 in the previous period[27] Other Financial Metrics - The company experienced a 587.46% increase in credit impairment losses, totaling -¥34,025,949.83, due to higher provisions for bad debts[13] - The company reported a financial expense of CNY 1,518,469.53, a significant change from a financial income of CNY -37,145,778.80 in the previous year[23] - Other income for the period was CNY 10,808,666.85, compared to CNY 4,828,808.07 in the same period last year, showing an increase in ancillary revenue streams[23] - The company issued 6,500,000 convertible bonds with a total fundraising amount of RMB 650,000,000, netting RMB 644,152,349.58 after expenses[18] Inventory and Current Assets - Total current assets rose to RMB 2,815,739,069.67, up from RMB 2,205,944,884.16, indicating a 27.6% increase[20] - The company's inventory decreased to RMB 353,263,788.33 from RMB 414,607,301.78, a decline of 14.8%[20] - Long-term equity investments increased to RMB 36,079,677.53 from RMB 27,761,457.81, reflecting a growth of 30%[20] - The company has a total of 1,565,935,639.15 in non-current assets, up from 1,335,306,985.57, which is an increase of 17.2%[20] Audit Information - The company did not conduct an audit for the third quarter report[28]

Financial Performance - The company's operating revenue for Q3 2023 was ¥962,960,799.14, representing a 10.05% increase year-on-year[6]. - The net profit attributable to shareholders decreased by 66.51% to ¥49,933,444.59 in Q3 2023 compared to the same period last year[6]. - The basic earnings per share fell by 70.00% to ¥0.12 for Q3 2023[6]. - Net profit for Q3 2023 was CNY 259,312,290.02, down 40.9% from CNY 438,568,058.44 in Q3 2022[24]. - Earnings per share decreased to CNY 0.64 from CNY 1.17 in the previous year, reflecting a decline of 45.3%[24]. - The total comprehensive income for Q3 2023 was CNY 258,988,097.54, down from CNY 438,857,249.46 in Q3 2022, reflecting a decrease of 41.0%[24]. Assets and Liabilities - Total assets increased by 23.73% to ¥4,381,674,708.82 as of September 30, 2023, compared to the end of the previous year[6]. - The total assets of the company reached RMB 4,381,674,708.82, compared to RMB 3,541,251,869.73 at the beginning of the year, marking an increase of 23.7%[20]. - Total liabilities increased to CNY 1,246,935,049.26, compared to CNY 761,959,868.02 in the previous year, marking a significant rise of 63.7%[21]. - The company's total assets reached CNY 4,381,674,708.82, compared to CNY 3,541,251,869.73 in the previous year, representing an increase of 23.8%[21]. Cash Flow - The net cash flow from financing activities for the first nine months of 2023 was ¥513,227,028.16, a 553.28% increase year-on-year[14]. - The net cash flow from operating activities for the period was ¥260,765,225.41, a decrease of 24.9% compared to ¥347,256,281.67 in the previous period[25]. - Cash inflow from financing activities amounted to ¥803,204,716.98, up 46.2% from ¥548,729,996.68[27]. - The net cash flow from financing activities was ¥513,227,028.16, significantly higher than ¥78,561,541.67 in the previous period[27]. - The net cash flow from investing activities was -¥567,641,699.79, worsening from -¥128,002,892.30 in the previous period[25]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,338[16]. - The top shareholder, Wang Chuanhua, holds 23.11% of the shares, amounting to 93,557,010 shares[16]. - The company has not disclosed any related party relationships among the top shareholders, except for Wang Chuanhua, Yin Yueming, and Wang Wenbo, who are identified as acting in concert[17]. Research and Development - Research and development expenses rose by 34.49% to ¥76,288,397.56 for the first nine months of 2023[12]. - Research and development expenses for the period were CNY 76,288,397.56, an increase of 34.5% compared to CNY 56,725,020.36 in the same period last year[23]. Inventory and Current Assets - The company's inventory decreased to RMB 353,263,788.33 from RMB 414,607,301.78, a decline of 14.8%[20]. - Total current assets rose to RMB 2,815,739,069.67, up from RMB 2,205,944,884.16, indicating a 27.6% increase[20]. - The company has a total of 1,565,935,639.15 in non-current assets, up from 1,335,306,985.57, which is an increase of 17.2%[20]. - Long-term equity investments increased to RMB 36,079,677.53 from RMB 27,761,457.81, reflecting a growth of 30%[20].

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2023-092 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 山东阳谷华泰化工股份有限公司关于 2021 年限制性股票激励计划第二个归属期归属条件成就的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本次符合归属条件的激励对象共 142 人 限制性股票拟归属数量：421.80 万股，占归属前公司总股本的 1.04% 归属价格：5.84 元/股 归属股票来源：公司向激励对象定向发行的本公司 A 股普通股股票 本次归属的限制性股票在相关手续办理完后、上市流通前，公司将发布相关 提示性公告，敬请投资者注意。 2、标的股票来源：公司向激励对象定向发行公司 A 股普通股股票。 3、限制性股票数量：本次激励计划授予的限制性股票为 1,406.00 万股，约占本 次激励计划草案公告时公司股本总额 37,513.1706 万股的 3.75%。本次激励计划为一 次性授予，无预留权益。 重要内容提示： 山东阳谷华泰化工股份有限公司（以下简称"公司"） ...